Pulsatilla: A Comprehensive Reference
1. Identity and Botanical Classification
1.1 Taxonomy and Nomenclature
The genus Pulsatilla contains about 40 species of perennial herbaceous plants native to meadows and prairies of North America, Europe, and Asia. Pulsatilla chinensis (Bunge) Regel, a synonym of Anemone chinensis Bunge, belongs to the family Ranunculaceae, and is a kind of perennial herb with rhizomes. In the past, Pulsatilla was considered a subgenus of the Anemone genus; therefore, P. pratensis is also known as Anemone pratensis or Meadow Anemone.
The three most medicinally significant species are:
- Pulsatilla vulgaris Mill. (European Pasqueflower): commonly called the European pasqueflower, belonging to the Ranunculaceae (buttercup) family. It is a low-growing perennial with feathery, finely divided leaves and nodding purple flowers that bloom in early spring, often around Easter, which is where the name "pasqueflower" comes from.
- Pulsatilla pratensis L. (Meadow Pasqueflower): Pulsatilla pratensis is the species most commonly used in European homeopathy. It can be mainly found in Europe and southwestern Asia.
- Pulsatilla chinensis (Bunge) Regel (Chinese Pasqueflower): known in Chinese medicine as Bai Tou Weng (白頭翁), it has been used for thousands of years to treat bacterial infections, especially of the digestive tract.
Additional closely related species used medicinally include Pulsatilla patens (L.) Mill., common names including Easter flower, Meadow anemone, Pasque flower, Pulsatilla, and Wind flower.
The name Pulsatilla is thought to be derived from the Latin word pulsare, meaning to beat or to hit.
1.2 Morphology
The small pasque flower is a perennial herb that can grow up to 40 cm tall. Its finely divided leaves but also the rest of the plant are covered with silky hair. In spring, it grows one nodding, bell-shaped flower per stem. These singular flowers have six dark purple petals around a showy yellow centre. After flowering, the yellow stamen develops into feathery seed heads.
1.3 Plant Part Used and Common Preparations
The above-ground parts of the blooming plant are harvested and used in herbal medicine. Since the fresh herb is toxic, the collected plants must be dried before further use. In the Eastern tradition, Pulsatilla chinensis (Bge.) Regel belongs to the Pulsatilla genus of the Ranunculaceae family, and its main medicinal part is its dry root.
Common preparations reported in the literature include:
- Dried herb/root decoctions: Typical dosing of the root in TCM is 9–15 grams in decoction.
- Liquid extracts: Used in Western herbal medicine, prepared from the dried plant material.
- Homeopathic dilutions: Homeopathic preparations of pulsatilla are reportedly used for sore nipples and mastitis, to reduce an overabundant milk supply, or to increase milk supply.
- Classical dried-herb preparations: Classical doses of the dried herb were from 0.1 to 0.4 g daily.
Pasque Flower herb consists of the dried, aboveground parts of Pulsatilla vulgaris and/or Pulsatilla pratensis.
2. Traditional and Historical Use
2.1 Traditional Chinese Medicine (TCM)
Pulsatilla chinensis (P. chinensis, Bai Tou Weng, 白頭翁) has been used medically in China for thousands of years for the treatment of diseases caused by bacteria, and it is rich in triterpenoid saponins. The earliest record of Pulsatilla chinensis is found in the Shennong Herbal Classic. P. chinensis is bitter in taste and cold in nature, as well as in stomach, kidney and large intestine meridians. Its efficacy mainly includes eliminating redundancy, cooling blood, stopping diarrhea, and reducing internal heat, and it is traditionally used for treatment of bacterial dysentery, as well as cold, heat, and wen diseases, red and pain of eyes.
It owns the property of bitter and cold, and has the functions of clearing heat and detoxifying, cooling blood and checking dysentery, and drying dampness and killing insects, and is used to treat dysentery with blood stool due to heat-toxicity, warm malaria with chill and fever, epistaxis, and hemorrhoids with blood stool.
Bai Tou Weng Tang (Pulsatilla Decoction) is a well-known Chinese formula for treating acute dysentery, sore stomach, and a frequent urge for a bowel movement with nothing coming out. This classical formula contains Pulsatillae Radix (Pulsatilla chinensis (Bunge) Regel), Coptidis Rhizoma (Coptis chinensis Franch.), Phellodendri Cortex (Phellodendron chinensis), and Fraxini Cortex (Fraxinus chinensis Roxb.).
2.2 European Herbal Tradition
Pulsatilla has been employed in Germany and other parts of Europe for the relief of amenorrhea and dysmenorrhea, and for other purposes. Baron Storck held the opinion that Anemone Pratensis had proved useful in amaurosis and other complaints of the eye, in secondary syphilis, and in cutaneous diseases. Pulsatilla is supposed also to possess emmenagogue properties and to exert an alterative influence over the mucous membranes, rendering it useful in ophthalmia, in catarrhal inflammation of the nostrils, throat, and respiratory passages.
Pulsatilla traditionally has been used as a sedative and diuretic, as well as to treat insomnia, cough, genitourinary disorders, menstrual irregularities, headache, otitis media, and eye conditions including cataract, glaucoma, and iritis.
2.3 Eclectic Medicine (19th–Early 20th Century, North America)
Long before homeopathy adopted pulsatilla, herbalists used small doses of the plant for a range of conditions. The Eclectic physicians of the late 1800s and early 1900s in the United States prescribed it particularly for problems of the female reproductive system: menstrual pain, lack of menstruation, and uterine disorders. They also used it for middle-ear infections, nervousness, insomnia, skin disorders, and wounds.
2.4 Indigenous North American Use
As reported by numerous ethnobotanists, including John Hellson, Harlan Smith, and Nancy Turner, Pulsatilla was used extensively by many First Nations tribes for headaches, rheumatism and childbirth complaints. Many varieties were burned and smoke was inhaled to control tension headache/migraine, and it was commonly used as a poultice for rheumatism among many plains tribes.
2.5 Homeopathic Tradition
Nowadays, Pulsatilla is a common homeopathic remedy for painful cramps and other menstrual disorders. In homeopathy it is mostly P. pratensis, the small pasque flower, that is used. Pulsatilla nigricans is the most frequently indicated homeopathic medicine for acute and chronic ear infections. Usually the infection is preceded by an upper respiratory tract infection with discharge of thick yellow or green nasal mucus.
3. Key Constituents and Active Compounds
3.1 Ranunculin, Protoanemonin, and Anemonin
Pulsatilla (Anemone pulsatilla and other related species) contains ranunculin, protoanemonin, and anemonin as well as triterpene saponins and flavonoids.
The chemical interconversion of these compounds is central to understanding Pulsatilla's pharmacology and toxicology:
Ranunculin, a glucoside, serves as a chemotaxonomic marker in Ranunculaceae plants. When these plants are damaged, an enzyme β-glucosidase triggers the conversion of ranunculin into protoanemonin through hydrolysis. Subsequently, protoanemonin undergoes cyclodimerization to form anemonin.
When the herb is cut, crushed, or freeze-dried, in the presence of water an enzyme is released that degrades the ranunculin to form protoanemonin. Protoanemonin is very irritating to the skin but is unstable and dimerises to form nontoxic anemonin. Protoanemonin proves to be rather unstable in aqueous-fermented extracts stored at 15 °C in the dark, and its concentration decreases rapidly over 12 months of storage independently of the plant species. The decrease was most pronounced when initial concentrations were high (decrease by about 70%).
Anemonin stands out as the optimal molecule for bioassays and demonstrates diverse biological properties, including anti-inflammatory, anti-infective, and antioxidant effects. Among these, anemonin exhibits the greatest promise in addressing conditions such as arthritis, cerebral ischemia, and ulcerative colitis. Its potential medical uses are enhanced by its capacity to inhibit nitric oxide synthesis and successfully counteract lipopolysaccharide-induced inflammation.
3.2 Triterpenoid Saponins (P. chinensis)
Saponins are thought to be the major active components of Pulsatilla, such as pulchinenoside A (PSA or anemoside A3, AA3), pulchinenoside C (PSC or anemoside B4, AB4), pulsatilla saponin D (PSD or SB365), and pulsatilloside E (PSE).
Pulsatilla chinensis is the chief herbal source of Pulsatilla Decoction, and it is rich in triterpenoid saponins, such as anemoside B4, anemoside A3, and 23-hydroxybetulinic acid. Anemoside B4 is the most abundant of that group and has been used as a quality control marker for Pulsatilla chinensis. As the major active component of Pulsatilla chinensis, anemoside B4 has also received attention as a pure compound for its therapeutic potential.
Up to date, 68 kinds of chemical constituents have been isolated and identified from P. chinensis. Among these compounds, triterpenoids, flavonoids, lignans, and coumarins are the major constituents.
3.3 Additional Constituents of P. vulgaris
Anemonin is the main active constituent in Pulsatilla vulgaris; however, it also contains small amounts of triterpenoid saponins, tannins, and volatile oil. Other identified constituents include flavonoids (delphinidin and pelargonidin glycosides), saponins (hederagenin as the aglycone), volatile oils including ranunculin (a glycoside), and carbohydrates such as arabinose, fructose, galactose, glucose, and rhamnose, as well as triterpenes such as β-amyrin and β-sitosterol.
4. Mechanisms of Action
4.1 Anticancer Mechanisms
The anti-tumor mechanism of Pulsatilla chinensis is mainly to inhibit cell proliferation, induce apoptosis, inhibit cell cycle, regulate cell energy metabolism, reverse drug resistance, induce autophagy, and inhibit angiogenesis.
In recent years, a large number of scientists have found that Anemoside B4 (AB4) had an anti-tumor effect. The inhibition rate of 100 μmol/L AB4 reached 46.26%. The mechanism may be related to up-regulation of the Bax/Bcl-2 ratio, activation of caspase-3, and cleavage of related proteins.
Research showed that root extract of P. vulgaris inhibited 12 signaling pathways in a cervical cancer cell line; the most potent activation inhibition was observed for MYC, Notch, Wnt, E2F, Ets, Stat3, Smad, Hedgehog, AP-1, and NF-κB, at a concentration of 40 µg/mL. The methanolic extracts of P. vulgaris enhanced apoptotic death and deregulated cellular proliferation, differentiation, and progression toward the neoplastic phenotype by altering key signaling molecules required for cell cycle progression.
4.2 Anti-Inflammatory Mechanisms
At doses of 12.5–50 mg/kg, anemoside B4 significantly suppressed xylene-induced mice ear edema. Furthermore, it ameliorated LPS-induced kidney and lung inflammation damage, which inhibited pro-inflammatory response by the NF-κB pathway in mice. In addition, anemoside B4 decreased CD4+/CD8+ ratio, inhibited splenic lymphocyte proliferation and decreased DNFB-induced changes of ear thickness. It was concluded that anemoside B4 presented anti-inflammatory and immune-modulatory activities in vivo.
Researchers suggest that anemonin may have a therapeutic action on intestinal inflammation by reducing the production of nitric oxide, endothelin-1, and soluble intercellular adhesion molecule-1.
4.3 Spasmolytic Mechanisms
The herb's ability to relieve painful muscle spasms, such as period pain, is supported by research done on isolated smooth muscles. The findings showed that Pulsatilla extract had the power to stop the muscle activity, depending on the extract dose. Pulsatilla has been shown to reduce the amplitude of uterine contractions in vitro.
4.4 Antimicrobial Mechanisms
P. chinensis triterpene saponins have high antifungal, antiparasitic, antibacterial, antiprotozoal, and molluscicidal activities. Several Pulsatilla species, including P. ambigua, P. chinensis, P. dahurica, and P. turczaninovii, have been employed to treat diarrhea, vaginal trichomoniasis, and bacterial infections.
5. Scientific Evidence by Area of Use
5.1 Oncology / Anticancer Activity
Evidence level: Preclinical (in vitro and animal); no completed human clinical trials identified.
In recent years, a large number of studies have reported that the pentacyclic triterpenoid saponins in P. chinensis (PC saponins) have significant anti-tumor activities in vitro and in vivo, such as inhibition of cell proliferation, effects of signal transduction, apoptosis and tumor invasion.
The anticancer activity of an active compound from Pulsatilla chinensis extracts, Pulsatilla saponin A (PsA), was examined in vitro and in vivo. It was demonstrated that PsA significantly inhibited the growth of human colon cancer HT-29 cells. This inhibitory activity was also observed when the compound was tested in a colon cancer xenograft mouse model. Additionally, synergistic antitumor effects of PsA and 5-FU on colon cancer cells were observed.
By bioassay-guided separation, an already known saponin, Pulsatilla saponin D, was isolated from the root of Pulsatilla koreana Nakai as an antitumor component when evaluated by in vivo antitumor activity as well as in vitro cytotoxic activity test. It showed potent inhibition rate of tumor growth (IR, 82%) at the dose of 6.4 mg/kg on BDF1 mice bearing LLC cells.
Research showed that root extract of P. vulgaris inhibited 12 signaling pathways in a cervical cancer cell line. The methanolic extracts of P. vulgaris enhanced apoptotic death and deregulated cellular proliferation, differentiation, and progression toward the neoplastic phenotype by altering key signaling molecules required for cell cycle progression. This is the first study to report the influence of P. vulgaris on cancer signaling pathways.
Limitation: All anticancer evidence to date originates from cell-line and animal studies. No randomized controlled human clinical trials have been published demonstrating anticancer efficacy of Pulsatilla preparations.
5.2 Inflammatory Bowel Disease / Colitis
Evidence level: Preclinical (in vitro and animal models); no independent human RCTs identified.
Conventional therapies based on drugs such as corticosteroids, mesalamine, and immunosuppression have serious side effects. Pulsatillae decoction (PD), serving as a classical prescription for the treatment of colitis in China, has been shown to exert prominent curative effects and good safety.
Studies aimed to evaluate the efficacy of modified Pulsatilla Decoction (MPD) in alleviating symptoms of UC in mice, specifically by protecting intestinal tissue and modulating intestinal flora. Thirty-two male Balb/c mice were randomly assigned to four groups. All groups except the Control group were administered 3% dextran sulfate sodium (DSS) in their drinking water for 7 days to induce acute UC.
Anemoside B4 has potential to be studied further as a natural compound-originated immunomodulatory agent for the treatment of inflammatory diseases such as ulcerative colitis and thus may represent one of the most important active components of Pulsatilla Decoction responsible for its anti-ulcerative colitis efficacy.
Limitation: Evidence is derived from murine colitis models. Rigorous human clinical trials specifically evaluating Pulsatilla or its isolated compounds for IBD in humans are lacking.
5.3 Antimicrobial and Antiparasitic Activity
Evidence level: Primarily in vitro; traditional use corroborated by some laboratory evidence.
Pulsatilla koreana, a species endemic to Korea, is an important herb used in traditional medicine to treat amoebic dysentery and malaria. In vitro studies have confirmed biological activity against various organisms: P. chinensis triterpene saponins have demonstrated high antifungal, antiparasitic, antibacterial, antiprotozoal, and molluscicidal activities.
The methanol extract of P. koreana showed strong nematicidal activity after 48 hours, with an LC50 value of 92.8 μg/mL.
Limitation: Most antimicrobial data are from in vitro experiments. Clinical evidence in human infections is minimal, and the activity against pathogens has not been validated in controlled human trials.
5.4 Menstrual and Reproductive Disorders
Evidence level: Preclinical in vitro data; traditional use documentation; no high-quality clinical trials.
Pulsatilla is used in the treatment of dysmenorrhea; in vitro it has been shown to reduce uterine contractions. In dried form, this herb is expected to cause little harm when used in the proper dosage range.
Protoanemonin is known to be a central nervous system depressant and to induce abortions. Utero-activity (both stimulant and depressant) has been documented for pulsatilla. In vivo sedative and antipyretic properties in rodents have been documented for anemonin and protoanemonin.
Limitation: Database searches of MEDLINE, AMED, and CINAHL revealed no clinical studies conducted with Pulsatilla vulgaris. Clinical trials using a liquid extract of Pulsatilla vulgaris have not been performed.
5.5 Sedative / Anxiolytic Activity
Evidence level: Animal studies; no human clinical trial evidence.
Historically, Pulsatilla has been used in the treatment of nervous conditions, including nervous exhaustion. It is also thought that Pulsatilla helps to calm nerves, in particular anxiety and mood swings linked to hormonal changes. This seems to be backed up by a study in mice comparing different homeopathic dilutions of Pulsatilla to a chemical drug for anxiety disorders. The results showed that the anxiety-reducing effect of the homeopathic preparation was comparable to the standard drug.
Limitation: Evidence is limited to animal models and uncontrolled observations. No rigorous human clinical trials on anxiolytic effects of Pulsatilla have been identified.
5.6 Otitis Media
Evidence level: Minimal; anecdotal clinical reports only.
Pulsatilla has shown promise in the treatment of otitis media in children. Herbalists have used this plant for many years to treat this condition. However, little primary research is available to support this use.
5.7 Galactagogue / Lactation
Evidence level: No clinical evidence.
Homeopathic preparations of pulsatilla are reportedly used for sore nipples and mastitis, to reduce an overabundant milk supply, or to increase milk supply. No scientifically valid clinical trials support any of these uses.
6. Body Systems and Health Areas of Association
- Gastrointestinal system: Pulsatilla chinensis is an important herb in Traditional Chinese Medicine and mostly used to treat the digestive system. Its saponins have been extensively studied in models of colitis and dysentery.
- Female reproductive system: Long-standing use for dysmenorrhea, amenorrhea, and menstrual irregularities across European, American Eclectic, and Asian medical traditions.
- Oncology (investigational): Pulsatilla saponins have shown promise in inducing cancer cell apoptosis, inhibiting tumor angiogenesis, and protecting organs via anti-inflammatory and antioxidant measures.
- Central nervous system: Traditional use as a sedative and anxiolytic, supported by animal experiments with anemonin and protoanemonin.
- Immune/inflammatory system: Anemoside B4 has demonstrated immunomodulatory activity in multiple animal models.
- Antimicrobial/antiparasitic: P. chinensis triterpene saponins have high antifungal, antiparasitic, antibacterial, antiprotozoal, and molluscicidal activities and are used in the treatment of inflammatory diseases, indigestion, premenstrual syndrome, and psychosomatic disorders.
- Ear, nose, and throat: Traditional and homeopathic use for otitis media and upper respiratory catarrh.
7. Dosage Forms and Dosages Reported in Studies
Note: The following dosages are taken directly from cited sources as reported, not as recommendations.
- TCM root decoction (P. chinensis): According to the Chinese Pharmacopoeia, the suggested dosage of P. chinensis ranges from 9 to 15 g.
- Classical dried herb (P. vulgaris/P. pratensis): Classical doses of the dried herb were from 0.1 to 0.4 g daily.
- Animal study (anemoside B4, anti-inflammatory): 12.5–50 mg/kg anemoside B4 significantly suppressed xylene-induced mice ear edema.
- Animal study (Pulsatilla saponin D, antitumor): Pulsatilla saponin D showed potent inhibition of tumor growth (IR, 82%) at the dose of 6.4 mg/kg on BDF1 mice bearing LLC cells.
- In vitro cancer study (anemoside B4): The inhibition rate of 100 μmol/L AB4 reached 46.26%.
- In vitro cancer signaling (P. vulgaris): Root extract of P. vulgaris inhibited 12 signaling pathways in a cervical cancer cell line at a concentration of 40 µg/mL.
- Overall human dosing: At this time there is not enough scientific information to determine an appropriate range of doses for pulsatilla.
8. Safety Considerations
8.1 Toxicity of the Fresh Plant
The fresh plant is extremely irritating to the skin, gastrointestinal tract, and mucous membranes. When it is harvested fresh, Pulsatilla vulgaris is toxic due to the presence of a glucoside called ranunculin. Ranunculin is a terpenoid lactone which is present in pulsatilla that is fresh and intact. In its fresh form, pulsatilla can cause serious irritation and blistering of the oral, esophageal, and gut mucosa.
8.2 Protoanemonin: The Primary Toxic Constituent
Literature review shows that protoanemonin is the most relevant constituent of these plants regarding potential toxicity. Based on structural alerts, protoanemonin is classified as a Cramer class III compound with the threshold of toxicological concern (TTC) of 180 μg/day in adults. Neither computer-aided toxicology methods (Toxtree and Derek Nexus®) nor a literature search revealed any evidence of genotoxic, carcinogenic, or teratogenic potential of protoanemonin.
Fresh extracts of Pulsatilla yield an oily substance with an acrid and peppery taste that has an ability to irritate the skin and mucous membranes. The oil breaks down into anemonic acid, isoanemonic acid, and anemonin. Anemonic acid is thought to be inert, while anemonin is a powerful irritant on par with cantharidin isolated from Spanish fly. In hot water, it volatilizes and can irritate the eyes, upper respiratory mucous membranes, and gastric membranes.
8.3 Overdose
Excessive (undefined amount) doses of the herb may cause severe gastritis, kidney, or urinary tract irritation. High doses of Pulsatilla vulgaris can damage the kidneys and urinary tract.
8.4 Contraindications
Pregnancy is a contraindication. Pulsatilla is fully contraindicated during pregnancy and lactation. This herb is also contraindicated in depression, psychosis, and in children. The uterotonic activity documented in animal studies provides a biological plausibility for the pregnancy contraindication.
Its use is not recommended by the German Commission E.
8.5 Allergic Reactions
Allergic reactions have been reported to pulsatilla.
8.6 Hepatorenal Considerations (P. chinensis)
The toxicity of this plant on the liver and kidney is notable; according to the Chinese pharmacopoeia, the suggested dosage of P. chinensis ranges from 9 to 15 g, thus it is vigilant when the dosage is beyond the safe range.
8.7 Drug Interactions
Its use with pharmaceutical analgesics is not recommended. There is a lack of clinical research assessing the effects of pulsatilla and rigorous randomised clinical trials are required. There is a lack of clinical safety and interaction data.
8.8 Adulteration Risk
Pulsatilla also may be adulterated by the presence of other more toxic species of Pulsatilla. Therefore, this herb should be restricted to use only by those trained in its use and familiar with its identification and contraindications.
8.9 Evidence Quality Summary
The majority of available research on pulsatilla has been carried out on Pulsatilla chinensis and Pulsatilla koreana. For the European species (P. vulgaris, P. pratensis), clinical trial evidence is essentially absent. For the Asian species, the preponderance of the evidence is preclinical — in vitro and animal — with only preliminary investigation into pharmacokinetics and safety in humans. Further attention should be paid to gathering information about toxicology data, quality-control measures, and the clinical value of the active compounds from P. chinensis.
References
Go back